Search for: "ACTAVIS"
Results 881 - 900
of 1,010
Sorted by Relevance
|
Sort by Date
11 Feb 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
10 Oct 2011, 12:31 am
"We can now confirm that the deadline to submit comments on Case C- 442/11 Novartis AG v Actavis UK Limited is 14 October 2011" writes the UK Intellectual Property Office, which adds "If you would like to comment on this case please e-mail policy@ipo.gsi.gov.uk before 14 October 2011". [read post]
7 Jun 2010, 5:06 am
The recent Court of Appeal decision in Actavis v Merck [2008] RPC 26 [noted by the IPKat here] reaffirmed the desirability of maintaining conformity with EPO practice as established in Board of Appeal decisions in this field, and so Swiss-type claims to second medical uses will no longer be allowed.Effect of this change - pre-grant applications7. [read post]
3 Apr 2017, 1:00 am
On Tuesday 4 April until Thursday 6 April, the Supreme Court will hear the appeal of Eli Lilly & Co v Actavis UK Ltd & Ors, and other cases. [read post]
31 May 2018, 7:53 am
For example, in addition to those points raised above, an area which has been subject to much debate is the appropriate remedy for cross-label infringement of second medical use patents – this may come as a result of the Supreme Court’s pending decision in Warner-Lambert v Actavis (if the patent is found to be valid and infringed), or we may have to wait a little longer. [read post]
9 Mar 2020, 3:19 pm
” Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48 (Lord Kitchin JSC). [read post]
1 Mar 2017, 6:38 am
Referring to its own decision in Actavis v Eli Lilly ([2015] EWCA Civ 555; [2015] Bus LR 1068), the Court took this opportunity to comment on the impossible burden that reliance on prosecution history places on the skilled reader if it were to be recognised as a legitimate aid to construction. [read post]
3 Aug 2011, 3:31 am
Paddock (Orange Book Blog) (Holman’s Biotech IP Blog) Cetrorelix – UK: Non-payment of Cetrorelix fee on time fatal for SPC: Case BLO/252/11 The Administrators of the Tulane Education Fund (The SPC Blog) Detrol (Tolterodine tartrate) – US: Pfizer files patent infringement complaint against Torrent Pharma in response to Para IV certification filing (Patent Docs) Galantamine – EU: CJEU ruling in Case C-427/09 Generics (UK) Ltd v Synaptech (The SPC Blog) (EPLAW) Memantine –… [read post]
18 May 2011, 12:33 am
Du Pont (EPLAW) Opana (Oxymorphone) – US: CAFC: important decision controlling BPAI obviousness holdings: In re Kao (Patently-O) (PharmaPatents) Silenor (Doxepin) – US: Somaxon sues Actavis over application to market generic Silenor (GenericsWeb) Tanakan (Ginko Biloba) – France: Mylan ordered to pay €17M to Ipsen for unfair competition by marketing Vitalogink to pharmacists as an “equivalent” to Tanakan (EPLAW) Valcyte (Valganciclovir) – US:… [read post]
18 Mar 2019, 2:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
12 Jun 2017, 6:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
15 Oct 2021, 9:43 am
Actavis, Inc.; and (2) whether courts reviewing antitrust challenges to patent settlements can disregard evidence of the strength of the patents at issue, as the U.S. [read post]
22 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
22 Aug 2013, 1:34 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals, which is now known as Actavis, Inc. [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
15 Jun 2011, 4:56 am
Actavis (Kluwer Patent Blog) Viagra (Sildenafil) – US: Patent infringement complaint filed in response to Para IV certification: Pfizer Inc. et al. v. [read post]
20 Jul 2020, 11:20 am
On the merits of the case, the Court considered that the judgment of 12 July 2017 from the UK Supreme Court – which, as readers will know, decided with effects in England, France, Italy and Spain, in response to a declaratory non-infringement action filed by Actavis, that the scope of protection of the patent is not limited to the salt mentioned in the claim (pemetrexed disodium) – was of relevance to deciding the matter. [read post]
28 Jan 2019, 1:00 am
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor, heard 19-20 Nov 2018. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
27 Jan 2010, 3:00 am
Aurobindo Pharma Limited (Patentcircle) India/US: Indian pharma sector ‘fares well’ in US disputes (PatLit) India: The woes of the grassroot innovator in the agricultural sector (Spicy IP) South Africa: Biopiracy in Alice – Schwabe Pharamaceuticals wishes to patent method for extracting active ingredient in cough medicine from pelargonium roots (Afro-IP) UK: Okay to split costs where actions are joined, says Court of Appeal: Actavis UK Ltd v Eli Lilly & Co Ltd (PatLit)… [read post]
